Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Previous close
¥18.80
Day range
¥18.10 - ¥18.90
Year range
¥18.10 - ¥34.18
Market cap
21.00B CNY
Avg Volume
10.88M
P/E ratio
28.75
Dividend yield
-
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 451.66M | -39.65% |
Operating expense | 352.82M | -10.37% |
Net income | 54.07M | -73.69% |
Net profit margin | 11.97 | -56.39% |
Earnings per share | 0.01 | -92.42% |
EBITDA | — | — |
Effective tax rate | 17.08% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 996.96M | 2.66% |
Total assets | 15.02B | 8.81% |
Total liabilities | 5.40B | 14.52% |
Total equity | 9.62B | — |
Shares outstanding | 1.12B | — |
Price to book | 2.18 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 54.07M | -73.69% |
Cash from operations | -76.18M | -159.24% |
Cash from investing | -377.61M | -1,101.60% |
Cash from financing | 122.77M | 153.23% |
Net change in cash | -331.02M | -414.37% |
Free cash flow | — | — |
About
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Founded
Sep 8, 1992
Website
Employees
1,902
